CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection.
Liu Z, Gao X, Kan C, Li L, Zhang Y, Gao Y, Zhang S, Zhou L, Zhao H, Li M, Zhang Z, Sun Y.
Liu Z, et al. Among authors: zhang s, zhang z, zhang y.
MedComm (2020). 2023 Jan 31;4(1):e208. doi: 10.1002/mco2.208. eCollection 2023 Feb.
MedComm (2020). 2023.
PMID: 36744219
Free PMC article.